BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Dato data lack means upside for Gilead; Padcev 'must-win' does win
Upbeat phase III findings outweighed less encouraging late-stage trial news, as big pharma provided a mixed bag of cancer findings – with one data batch to form the basis...

More in BioWorld

BioWorld MedTech

Annalise.ai software improves radiologists’ diagnostic accuracy and speed
An artificial intelligence (AI) tool developed by Annalise.ai Pty Ltd. was able to improve radiologists’ accuracy in detecting abnormalities on non-contrast computed...

More in BioWorld MedTech

BioWorld Science

Brain path could relieve pain as an alternative to opioids without producing dependence
Scientists at the University of Chicago have discovered a signaling pathway guided by nicotinic acetylcholine receptors (nAChRs) that could relieve pain even when tolerance...

More in BioWorld Science

BioWorld Asia

Starpharma’s dendrimer platform delivers impressive results in bowel, ovarian cancer
Starpharma Holdings Ltd.'s nanoscale drug delivery technology shows enhanced safety and durable responses in phase II trials compared to standard of care therapies in...

More in BioWorld Asia

BioWorld Insider Podcast

Google’s Scott Penberthy joins the podcast for a visionary discussion that scans the horizon for startling changes artificial intelligence will bring to drug development in the relatively near future.